Clinical and economic burden of COPD in a medicaid population.

To evaluate the clinical and economic burden of COPD patients to Medicaid.
Retrospective, observational matched cohort design.
We calculated the incremental costs incurred and medical resources used by COPD patients relative to those without COPD. Data were obtained from 8 Medicaid states during 2003-2007. COPD patients were defined as Medicaid beneficiaries ≥40 years with a COPD diagnosis (ICD-9 CM: 491.xx, 492.xx, 496.xx) and treated with maintenance drugs for COPD. Patients were matched (1:3) to Medicaid beneficiaries without a COPD diagnosis on age, gender, race, index year, Medicare/Medicaid dual eligibility, and use of long-term care. Results were stratified by Medicare/Medicaid dual eligibility status and race.
A total of 10,221 COPD and 30,663 non-COPD patients were included. Cohorts were on average 65 years of age, 80% White, and 64.8% having Medicare/Medicaid dual eligibility. Inpatient hospitalizations and home healthcare visits/durable medical equipment were primary drivers of incremental medical costs. COPD patients were more than twice as likely to have a hospitalization (odds ratio [95% confidence interval] = 2.32 [2.19, 2.45]) or home healthcare visit/durable medical equipment (2.95 [2.82, 3.08]) compared to non-COPD patients. Medicaid incurred $2118/year in incremental costs due to COPD. On average, incremental costs were 7 times greater for non-dual-eligible patients ($4917) compared to dual-eligible patients ($667), and were more than double for Blacks compared to Whites ($4141 vs $1593).
COPD imposes a substantial economic and clinical burden on the Medicaid program; this burden differs by dual eligibility status and race.
AuthorsAnna O D'Souza, Manan Shah, Amol D Dhamane, Anand A Dalal
JournalCOPD (COPD) Vol. 11 Issue 2 Pg. 212-20 (Apr 2014) ISSN: 1541-2563 [Electronic] England
PMID24111752 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
  • Aged
  • Cost of Illness
  • Ethnic Groups (statistics & numerical data)
  • European Continental Ancestry Group (statistics & numerical data)
  • Female
  • Health Care Costs
  • Health Services (economics, utilization)
  • Hospitalization (economics, statistics & numerical data)
  • Humans
  • Male
  • Medicaid
  • Medicare
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive (economics, epidemiology, therapy)
  • Retrospective Studies
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: